Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2014

Open Access 01-12-2014 | Case report

Successful treatment in a case of Propionibacterium acnes-associated sarcoidosis with clarithromycin administration: a case report

Authors: Nobuo Takemori, Masaya Nakamura, Masaru Kojima, Yoshinobu Eishi

Published in: Journal of Medical Case Reports | Issue 1/2014

Login to get access

Abstract

Introduction

Sarcoidosis is recognized as a multiorgan disorder characterized by the presence of non-caseating granulomas in the involved tissues. It has been suggested that sarcoidosis might be due to the exposure to infectious or non-infectious agents in genetically susceptible individuals. In particular, Propionibacterium acnes and Mycobacterium tuberculosis have been considered causative microorganisms. We report a case of P. acnes-associated sarcoidosis in which a drastic improvement was achieved with clarithromycin administration. A possible mechanism of clarithromycin action is discussed.

Case presentation

A 78-year-old Japanese-Mongoloid woman with P. acnes-associated sarcoidosis presented with a persisting fever, joint pains and generalized lymph node swelling. The diagnosis of sarcoidosis was confirmed by pathological and immunohistochemical studies of a biopsied lymph node. In this case, an oral administration of clarithromycin was applied. Soon after the initiation of this treatment her symptoms as well as lymph node swelling disappeared. The clarithromycin treatment was discontinued 3.5 months after its initiation. She is currently in good condition. The pathological analysis of her lymph node, which was obtained during the clarithromycin treatment, suggested an apoptosis-inducing effect of clarithromycin on the sarcoid granulomas.

Conclusions

Clarithromycin was found to be effective for treating sarcoidosis and seems to have important pharmacological effects such as immunosuppression, immunomodulation and induction of apoptosis in addition to its antimicrobial role. In this case, apoptosis in the sarcoid granulomas induced by clarithromycin administration might have resulted in satisfactory improvement.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, Eklund A, Kitaichi M, Lynch J, Rizzato G, Rose C, Selroos O, Semenzato G, Sharma OP: ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1999, 16 (2): 149-173.PubMed Hunninghake GW, Costabel U, Ando M, Baughman R, Cordier JF, du Bois R, Eklund A, Kitaichi M, Lynch J, Rizzato G, Rose C, Selroos O, Semenzato G, Sharma OP: ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1999, 16 (2): 149-173.PubMed
2.
go back to reference Iannuzzi MC, Rybicki BA, Teirstein AS: Sarcoidosis. N Engl J Med. 2007, 357 (21): 2153-2165. 10.1056/NEJMra071714.CrossRefPubMed Iannuzzi MC, Rybicki BA, Teirstein AS: Sarcoidosis. N Engl J Med. 2007, 357 (21): 2153-2165. 10.1056/NEJMra071714.CrossRefPubMed
3.
go back to reference Negi M, Takemura T, Guzman J, Uchida K, Furukawa A, Suzuki Y, Iida T, Ishige I, Minami J, Yamada T, Kawachi H, Costabel U, Eishi Y: Localization of Propionibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium. Mod Pathol. 2012, 25 (9): 1284-1297. 10.1038/modpathol.2012.80.CrossRefPubMedPubMedCentral Negi M, Takemura T, Guzman J, Uchida K, Furukawa A, Suzuki Y, Iida T, Ishige I, Minami J, Yamada T, Kawachi H, Costabel U, Eishi Y: Localization of Propionibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium. Mod Pathol. 2012, 25 (9): 1284-1297. 10.1038/modpathol.2012.80.CrossRefPubMedPubMedCentral
4.
go back to reference Homma JY, Homma JYC, Abe C, Chosa H, Ueda K, Saegusa J, Nakayama M, Homma H, Washizaki M, Okano H: Bacteriological investigation on biopsy specimens from patients with sarcoidosis. Jpn J Exp Med. 1978, 48 (3): 251-255.PubMed Homma JY, Homma JYC, Abe C, Chosa H, Ueda K, Saegusa J, Nakayama M, Homma H, Washizaki M, Okano H: Bacteriological investigation on biopsy specimens from patients with sarcoidosis. Jpn J Exp Med. 1978, 48 (3): 251-255.PubMed
5.
go back to reference Culić O, Eraković V, Parnham MJ: Anti-inflammatory effects of macrolide antibiotics. Eur J Pharmacol. 2001, 429 (1–3): 209-229.PubMed Culić O, Eraković V, Parnham MJ: Anti-inflammatory effects of macrolide antibiotics. Eur J Pharmacol. 2001, 429 (1–3): 209-229.PubMed
6.
go back to reference Kanoh S, Rubin BK: Mechanism of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev. 2010, 23 (3): 590-615. 10.1128/CMR.00078-09.CrossRefPubMedPubMedCentral Kanoh S, Rubin BK: Mechanism of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev. 2010, 23 (3): 590-615. 10.1128/CMR.00078-09.CrossRefPubMedPubMedCentral
7.
go back to reference Wyllie AH, Kerr JFR, Currie AR: Cell-death: the significance of apoptosis. Int Rev Cytol. 1980, 68: 251-306.CrossRefPubMed Wyllie AH, Kerr JFR, Currie AR: Cell-death: the significance of apoptosis. Int Rev Cytol. 1980, 68: 251-306.CrossRefPubMed
8.
go back to reference McGrath DS, Goh N, Foley PJ, du Bois RM: Sarcoidosis: genes and microbes―soil or seed?. Sarcoidosis Vasc Diffuse Lung Dis. 2001, 18 (2): 149-164.PubMed McGrath DS, Goh N, Foley PJ, du Bois RM: Sarcoidosis: genes and microbes―soil or seed?. Sarcoidosis Vasc Diffuse Lung Dis. 2001, 18 (2): 149-164.PubMed
9.
go back to reference du Bois RM, Goh N, McGrath D, Cullinan P: Is there a role for microorganisms in the pathogenesis of sarcoidosis?. J Intern Med. 2003, 253 (1): 4-17. 10.1046/j.1365-2796.2003.01073.x.CrossRefPubMed du Bois RM, Goh N, McGrath D, Cullinan P: Is there a role for microorganisms in the pathogenesis of sarcoidosis?. J Intern Med. 2003, 253 (1): 4-17. 10.1046/j.1365-2796.2003.01073.x.CrossRefPubMed
10.
go back to reference Drake WP, Newman LS: Mycobacterial antigens may be important in sarcoidosis pathogenesis. Curr Opin Pulm Med. 2006, 12 (5): 359-363. 10.1097/01.mcp.0000239554.01068.94.CrossRefPubMed Drake WP, Newman LS: Mycobacterial antigens may be important in sarcoidosis pathogenesis. Curr Opin Pulm Med. 2006, 12 (5): 359-363. 10.1097/01.mcp.0000239554.01068.94.CrossRefPubMed
11.
go back to reference Ishige I, Usui Y, Takemura T, Eishi Y: Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet. 1999, 354 (9173): 120-123. 10.1016/S0140-6736(98)12310-3.CrossRefPubMed Ishige I, Usui Y, Takemura T, Eishi Y: Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet. 1999, 354 (9173): 120-123. 10.1016/S0140-6736(98)12310-3.CrossRefPubMed
12.
go back to reference Eishi Y, Suga M, Ishige I, Kobayashi D, Yamada T, Takemura T, Takizawa T, Koike M, Kudoh S, Costabel U, Guzman J, Rizzato G, Gambacorta M, du Bois R, Nicholson AG, Sharma OP, Ando M: Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol. 2002, 40 (1): 198-204. 10.1128/JCM.40.1.198-204.2002.CrossRefPubMedPubMedCentral Eishi Y, Suga M, Ishige I, Kobayashi D, Yamada T, Takemura T, Takizawa T, Koike M, Kudoh S, Costabel U, Guzman J, Rizzato G, Gambacorta M, du Bois R, Nicholson AG, Sharma OP, Ando M: Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol. 2002, 40 (1): 198-204. 10.1128/JCM.40.1.198-204.2002.CrossRefPubMedPubMedCentral
13.
go back to reference Yamada T, Eishi Y, Ikeda S, Ishige I, Suzuki T, Takemura T, Takizawa T, Koike M: In situ localization of Propionibacterium acnes DNA in lymph nodes from sarcoidosis patients by signal amplification with catalysed reporter deposition. J Pathol. 2002, 198 (4): 541-547. 10.1002/path.1243.CrossRefPubMed Yamada T, Eishi Y, Ikeda S, Ishige I, Suzuki T, Takemura T, Takizawa T, Koike M: In situ localization of Propionibacterium acnes DNA in lymph nodes from sarcoidosis patients by signal amplification with catalysed reporter deposition. J Pathol. 2002, 198 (4): 541-547. 10.1002/path.1243.CrossRefPubMed
14.
go back to reference Zissel G, Prasse A, Müller-Quernheim J: Sarcoidosis-immunopathogenetic concepts. Semin Respir Crit Care Med. 2007, 28 (1): 3-14. 10.1055/s-2007-970329.CrossRefPubMed Zissel G, Prasse A, Müller-Quernheim J: Sarcoidosis-immunopathogenetic concepts. Semin Respir Crit Care Med. 2007, 28 (1): 3-14. 10.1055/s-2007-970329.CrossRefPubMed
15.
go back to reference Moller DR, Forman JD, Liu MC, Noble PW, Greenlee BM, Vyas P, Holden DA, Forrester JM, Lazarus A, Wysocka M, Trinchieri G, Karp C: Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol. 1996, 156 (12): 4952-4960.PubMed Moller DR, Forman JD, Liu MC, Noble PW, Greenlee BM, Vyas P, Holden DA, Forrester JM, Lazarus A, Wysocka M, Trinchieri G, Karp C: Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol. 1996, 156 (12): 4952-4960.PubMed
16.
go back to reference Minami J, Eishi Y, Ishige Y, Kobayashi I, Ishige I, Kobayashi D, Ando N, Uchida K, Ikeda S, Sorimachi N, Karasuyama H, Takemura T, Takizawa T, Koike M: Pulmonary granulomas caused experimentally in mice by a recombinant trigger-factor protein of Propionibacterium acnes. J Med Dent Sci. 2003, 50 (4): 265-274.PubMed Minami J, Eishi Y, Ishige Y, Kobayashi I, Ishige I, Kobayashi D, Ando N, Uchida K, Ikeda S, Sorimachi N, Karasuyama H, Takemura T, Takizawa T, Koike M: Pulmonary granulomas caused experimentally in mice by a recombinant trigger-factor protein of Propionibacterium acnes. J Med Dent Sci. 2003, 50 (4): 265-274.PubMed
17.
go back to reference Takemori N, Saito N, Tachibana N, Hayashishita N, Miyazaki T: A case report of multiple myeloma, with special reference to M-protein-containing dense bodies in erythroid cells: an immunoelectron microscopic study. J Clin Electron Microsc. 1987, 20 (2): 151-167. Takemori N, Saito N, Tachibana N, Hayashishita N, Miyazaki T: A case report of multiple myeloma, with special reference to M-protein-containing dense bodies in erythroid cells: an immunoelectron microscopic study. J Clin Electron Microsc. 1987, 20 (2): 151-167.
18.
go back to reference Bachelez H, Senet P, Cadranel J, Kaoukhov A, Dubertret L: The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol. 2001, 137 (1): 69-73.CrossRefPubMed Bachelez H, Senet P, Cadranel J, Kaoukhov A, Dubertret L: The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol. 2001, 137 (1): 69-73.CrossRefPubMed
19.
go back to reference Miyazaki E, Ando M, Fukami T, Nureki S, Eishi Y, Kumamoto T: Minocycline for the treatment of sarcoidosis: is the mechanism of action immunomodulating or antimicrobial effect?. Clin Rheumatol. 2008, 27 (9): 1195-1197. 10.1007/s10067-008-0903-3.CrossRefPubMed Miyazaki E, Ando M, Fukami T, Nureki S, Eishi Y, Kumamoto T: Minocycline for the treatment of sarcoidosis: is the mechanism of action immunomodulating or antimicrobial effect?. Clin Rheumatol. 2008, 27 (9): 1195-1197. 10.1007/s10067-008-0903-3.CrossRefPubMed
20.
go back to reference Baba K, Yamaguchi E, Matsui S, Niwa S, Onoe K, Yagi T, Hattori T, Ozawa H, Hara K: A case of sarcoidosis with multiple endobronchial mass lesions that disappeared with antibiotics. Sarcoidosis Vasc Diffuse Lung Dis. 2005, 23 (1): 78-79. Baba K, Yamaguchi E, Matsui S, Niwa S, Onoe K, Yagi T, Hattori T, Ozawa H, Hara K: A case of sarcoidosis with multiple endobronchial mass lesions that disappeared with antibiotics. Sarcoidosis Vasc Diffuse Lung Dis. 2005, 23 (1): 78-79.
21.
go back to reference Takemori N, Kaneko H, Nakamura M, Kojima M: Complete remission of methotrexate-related Epstein–Barr-virus-associated Hodgkin-like lymphoma following withdrawal of MTX coupled with clarithromycin administration. Case Rep Hematol. 2012, 2012: 658745-doi:10.1155/2012/658745PubMedPubMedCentral Takemori N, Kaneko H, Nakamura M, Kojima M: Complete remission of methotrexate-related Epstein–Barr-virus-associated Hodgkin-like lymphoma following withdrawal of MTX coupled with clarithromycin administration. Case Rep Hematol. 2012, 2012: 658745-doi:10.1155/2012/658745PubMedPubMedCentral
22.
go back to reference Hamada K, Mikasa K, Yunou Y, Kurioka T, Majima T, Narita N, Kita E: Adjuvant effect of clarithromycin on chemotherapy for murine lung cancer. Chemotherapy. 2000, 46 (1): 49-61. 10.1159/000007256.CrossRefPubMed Hamada K, Mikasa K, Yunou Y, Kurioka T, Majima T, Narita N, Kita E: Adjuvant effect of clarithromycin on chemotherapy for murine lung cancer. Chemotherapy. 2000, 46 (1): 49-61. 10.1159/000007256.CrossRefPubMed
23.
go back to reference Majima T, Mikasa K, Hamada K, Konishi M, Maeda K, Sakamoto M, Yoshimoto E, Murakawa K, Ueda K, Kita E, Narita N: Changes of cytokine mRNA in peripheral blood mononuclear cells from unresectable non-small cell lung cancer patients before and after clarithromycin therapy. Jpn J Chemother. 1999, 47 (6): 345-348. Majima T, Mikasa K, Hamada K, Konishi M, Maeda K, Sakamoto M, Yoshimoto E, Murakawa K, Ueda K, Kita E, Narita N: Changes of cytokine mRNA in peripheral blood mononuclear cells from unresectable non-small cell lung cancer patients before and after clarithromycin therapy. Jpn J Chemother. 1999, 47 (6): 345-348.
24.
go back to reference Sakamoto M, Mikasa K, Hamada K, Teramoto S, Konishi M, Maeda K, Tsujimoto M, Hirai T, Mori K, Ueda K, Sawaki M, Kita E, Narita N: Long-term clarithromycin treatment for cancer cachexia of inoperable non-small cell lung cancer patients. Jpn J Chemother. 1996, 44 (12): 879-882. Sakamoto M, Mikasa K, Hamada K, Teramoto S, Konishi M, Maeda K, Tsujimoto M, Hirai T, Mori K, Ueda K, Sawaki M, Kita E, Narita N: Long-term clarithromycin treatment for cancer cachexia of inoperable non-small cell lung cancer patients. Jpn J Chemother. 1996, 44 (12): 879-882.
25.
go back to reference Takeshita K, Yamagishi I, Harada M, Otomo S, Nakagawa T, Mizushima Y: Immunological and anti-inflammatory effects of clarithromycin: inhibition of interleukin 1 production of murine peritoneal macrophages. Drugs Exp Clin Res. 1989, 15 (11–12): 527-533.PubMed Takeshita K, Yamagishi I, Harada M, Otomo S, Nakagawa T, Mizushima Y: Immunological and anti-inflammatory effects of clarithromycin: inhibition of interleukin 1 production of murine peritoneal macrophages. Drugs Exp Clin Res. 1989, 15 (11–12): 527-533.PubMed
26.
go back to reference Morikawa K, Zhang J, Nonaka M, Morikawa S: Modulatory effect of macrolide antibiotics on the Th1- and Th2-type cytokine production. Int J Antimicrob Agents. 2002, 19 (1): 53-59. 10.1016/S0924-8579(01)00457-5.CrossRefPubMed Morikawa K, Zhang J, Nonaka M, Morikawa S: Modulatory effect of macrolide antibiotics on the Th1- and Th2-type cytokine production. Int J Antimicrob Agents. 2002, 19 (1): 53-59. 10.1016/S0924-8579(01)00457-5.CrossRefPubMed
27.
go back to reference Sugiyama K, Shirai R, Mukae H, Ishimoto H, Nagata T, Sakamoto N, Ishii H, Nakayama S, Yanagihara K, Mizuta Y, Kohno S: Differing effects of clarithromycin and azithromycin on cytokine production by murine dendritic cells. Clin Exp Immunol. 2007, 147 (3): 540-546. 10.1111/j.1365-2249.2007.03299.x.CrossRefPubMedPubMedCentral Sugiyama K, Shirai R, Mukae H, Ishimoto H, Nagata T, Sakamoto N, Ishii H, Nakayama S, Yanagihara K, Mizuta Y, Kohno S: Differing effects of clarithromycin and azithromycin on cytokine production by murine dendritic cells. Clin Exp Immunol. 2007, 147 (3): 540-546. 10.1111/j.1365-2249.2007.03299.x.CrossRefPubMedPubMedCentral
28.
go back to reference Kikuchi T, Hagiwara K, Honda Y, Gomi K, Kobayashi T, Takahashi H, Tokue Y, Watanabe A, Nukiwa T: Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-κB transcription factors. J Antimicrob Chemother. 2002, 49 (5): 745-755. 10.1093/jac/dkf008.CrossRefPubMed Kikuchi T, Hagiwara K, Honda Y, Gomi K, Kobayashi T, Takahashi H, Tokue Y, Watanabe A, Nukiwa T: Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-κB transcription factors. J Antimicrob Chemother. 2002, 49 (5): 745-755. 10.1093/jac/dkf008.CrossRefPubMed
29.
go back to reference Sassa K, Mizushima Y, Kobayashi M: Differential modulatory effects of clarithromycin on the production of cytokines by a tumor. Antimicrob Agents Chemother. 1999, 43 (11): 2787-2789.PubMedPubMedCentral Sassa K, Mizushima Y, Kobayashi M: Differential modulatory effects of clarithromycin on the production of cytokines by a tumor. Antimicrob Agents Chemother. 1999, 43 (11): 2787-2789.PubMedPubMedCentral
30.
go back to reference Ishimatsu Y, Kadota J, Iwashita T, Nagata T, Ishii H, Shikuwa C, Kaida H, Mukae H, Kohno S: Macrolide antibiotics induce apoptosis of human peripheral lymphocytes in vitro. Int J Antimicrob Agents. 2004, 24 (3): 49-55.CrossRef Ishimatsu Y, Kadota J, Iwashita T, Nagata T, Ishii H, Shikuwa C, Kaida H, Mukae H, Kohno S: Macrolide antibiotics induce apoptosis of human peripheral lymphocytes in vitro. Int J Antimicrob Agents. 2004, 24 (3): 49-55.CrossRef
Metadata
Title
Successful treatment in a case of Propionibacterium acnes-associated sarcoidosis with clarithromycin administration: a case report
Authors
Nobuo Takemori
Masaya Nakamura
Masaru Kojima
Yoshinobu Eishi
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2014
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-8-15

Other articles of this Issue 1/2014

Journal of Medical Case Reports 1/2014 Go to the issue